simvastatin has been researched along with Multiple Sclerosis, Chronic Progressive in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chataway, J; Eshaghi, A; Frost, C; Heslegrave, A; Holdsworth, KP; Katsanouli, T; Nicholas, JM; Wellington, H; Williams, TE; Zetterberg, H | 1 |
| Abushamma, A; Corbett, AM; Gagle, S; Johnson, A; Nagarajan, D; Sharma, N; Sulehria, T | 1 |
| Binks, S; Cardoso, MJ; Chan, D; Chataway, J; Frost, C; Nicholas, JM; Nicholas, R; Ourselin, S; Wilkie, D | 1 |
| Feinstein, A | 1 |
| Alexander, DC; Barkhof, F; Cardoso, MJ; Chan, D; Chataway, J; Ciccarelli, O; Eshaghi, A; Greenwood, J; Kievit, RA; Nicholas, J; Nicholas, R; Ourselin, S; Prados, F; Sudre, CH; Thompson, AJ | 1 |
| Kmietowicz, Z | 1 |
| Palace, J; Robertson, N | 1 |
| Alsanousi, A; Anderson, V; Bangham, CR; Calder, VL; Chan, D; Chataway, J; Clegg, S; Fox, NC; Frost, C; Greenwood, J; Hunter, K; MacManus, D; Nicholas, JM; Nicholas, R; Nielsen, C; Schuerer, N; Wilkie, D | 1 |
| Malkki, H | 1 |
| Auer, J; Berent, R | 1 |
| Baker, D; Giovannoni, G; Schmierer, K | 1 |
| Chataway, J | 1 |
4 trial(s) available for simvastatin and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial.
Topics: Adult; Biomarkers; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neurofilament Proteins; Neuroprotective Agents; Outcome Assessment, Health Care; Simvastatin | 2022 |
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.
Topics: Adult; Cognitive Dysfunction; Double-Blind Method; Executive Function; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Memory Disorders; Middle Aged; Multiple Sclerosis, Chronic Progressive; Outcome Assessment, Health Care; Quality of Life; Simvastatin | 2017 |
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Atrophy; Brain; Cytokines; Disabled Persons; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Simvastatin; Young Adult | 2014 |
Multiple sclerosis: could simvastatin slow down secondary progressive MS?
Topics: Anticholesteremic Agents; Female; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Chronic Progressive; Simvastatin; Time Factors | 2014 |
8 other study(ies) available for simvastatin and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis?
Topics: Animals; Ascorbic Acid; Cell Proliferation; Drug Therapy, Combination; Female; Fluoxetine; Lateral Ventricles; Male; Multiple Sclerosis, Chronic Progressive; Neural Stem Cells; Neurogenesis; Rats, Sprague-Dawley; Sex Factors; Simvastatin | 2020 |
Multiple sclerosis: Treatment of cognitive impairment in secondary progressive MS.
Topics: Clinical Trials, Phase II as Topic; Cognitive Dysfunction; Depression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multiple Sclerosis, Chronic Progressive; Simvastatin | 2017 |
Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis.
Topics: Adult; Atrophy; Brain; Causality; Cholesterol; Clinical Trials as Topic; Disease Progression; Humans; Middle Aged; Models, Statistical; Multiple Sclerosis, Chronic Progressive; Simvastatin | 2019 |
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Topics: Adolescent; Adult; Aged; Humans; Middle Aged; Multiple Sclerosis, Chronic Progressive; Randomized Controlled Trials as Topic; Simvastatin; Young Adult | 2014 |
Modifying disability in progressive multiple sclerosis.
Topics: Brain; Disabled Persons; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multiple Sclerosis, Chronic Progressive; Simvastatin | 2014 |
Simvastatin in patients with progressive multiple sclerosis.
Topics: Brain; Disabled Persons; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multiple Sclerosis, Chronic Progressive; Simvastatin | 2014 |
Simvastatin in patients with progressive multiple sclerosis.
Topics: Brain; Disabled Persons; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multiple Sclerosis, Chronic Progressive; Simvastatin | 2014 |
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Topics: Brain; Disabled Persons; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multiple Sclerosis, Chronic Progressive; Simvastatin | 2014 |